BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lew D, Yoon SM, Yan X, Robbins L, Haritunians T, Liu Z, Li D, McGovern DP. Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients. World J Gastroenterol 2017; 23(40): 7265-7273 [PMID: 29142473 DOI: 10.3748/wjg.v23.i40.7265]
URL: https://www.wjgnet.com/1007-9327/full/v23/i40/7265.htm
Number Citing Articles
1
Dalin Li, Talin Haritunians, Carol Landers, Alka A Potdar, Shaohong Yang, Hailiang Huang, L Philip Schumm, Mark Daly, Stephan R Targan, Dermot P B McGovern. Late-Onset Crohn’s Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like CharacteristicsInflammatory Bowel Diseases 2018; 24(11): 2413 doi: 10.1093/ibd/izy148
2
Maya Zvuloni, Manar Matar, Rachel Levi, Dror S. Shouval, Raanan Shamir, Amit Assa. High anti-TNFα Concentrations Are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology & Nutrition 2021; 73(6): 717 doi: 10.1097/MPG.0000000000003240